Huaren Pharmaceuticals' proposed acquisition of Korean medicine and cosmetics marriage will have a "spark"?

On the evening of October 17th, Huaren Pharmaceuticals, which had earlier announced that it would acquire a well-known cosmetics company in China, finally lifted the mystery of the target, which was acquired by Han post cosmetics Co., Ltd. (hereinafter referred to as Han Post).
korean name, you must not listen less! As one of the main domestic cosmetics brands, Han can be said to play a good marketing.
In 2012, Han posted a huge advertisement of 120 million yuan in Jiangsu Satellite TV, becoming the advertising king of China's cosmetics industry that year, and in 2014, Han later took the right to advertise the Guangzhou landmark "Little Barbarian Waist" for five years. In addition, Han has also been named CCTV Spring Festival Evening, CCTV Lantern Gala, Zhejiang Satellite TV New Year concert and variety show "Cross-border Song King", Huang Xiaoming, Quan Zhixian and Jin Xiuxian have been the spokesman for Han.
According to Huaren Pharmaceuticals announcement disclosed that Han was established in 2008, the legal representative is Wang An, registered capital of 65.3061 million yuan, the scope of business for cosmetics manufacturing, cosmetics and sanitary products wholesale and retail, etc. ;
note that Sequoia Capital, a well-known venture capital fund, has emerged on the list of shareholders after South Korea. Data show that in 2014 and 2015, Sequoia Capital invested in Korea twice. At present, beijing Sequoia Xinyuan Equity Investment Center (Limited Partnership) and Beijing Sequoia Mingde Equity Investment Center (Limited Partnership) have jointly paid out about 12.54 million yuan to Korea, with a total shareholding of about 19.20%.
Korea post-Korean official website shows that after ten years of development, Korea has become a Korea HANCOS, Shanghai branch, e-commerce, ten long-term manufacturing subsidiaries and direct business units of large groups, which owns "Korean after", "Dawin", "Hancos", "mask control" and other brands.
"Daily Economic News" reporter noted that, as the purchaser of Huaren Pharmaceuticals, is a pharmaceutical health services industry, mainly engaged in non-PVC soft bag high-volume preparations and supporting packages, pipeline research and development, production and sales, products covering basic infusions, therapeutic infusions, nutritional infusions, peritometrial dialysis. Huaren Pharmaceuticals' semi-annual report shows that in the first half of 2018, the company achieved operating income of 651 million yuan, up 10.95 percent year-on-year, and net profit of 16.4089 million yuan, up 93.82 percent year-on-year.
huaren pharmaceutical industry said that the transaction will help the company from the existing pharmaceutical, medical services, preventive health care and other medical and health industries, extended to skin care, beauty and other beautiful health industry, to create "medical health and beauty health" two major consumer upgrade scenarios, create new profit growth points, will also help to enhance the integrity of the company's business structure, enhance the company's future profitability. (Daily Economic News)